Allied Market Research publiserte en rapport med tittelen “Orgel-på-chip-marked etter type (hjerte på brikke, menneske på brikke, tarm på brikke, nyre på brikke, lever på brikke, lunge på brikke): Global Opportunity Analysis and Industry Forecast, 2020-2030.I følge rapporten ble den globale organ-på-brikke-industrien estimert til $103,44 millioner i 2020, og forventes å nå $1,6 milliarder innen 2030, og registrere en CAGR på 31,1% fra 2021 til 2030.
Hva er den estimerte bransjestørrelsen på Organ-on-Chip?
Den totale markedsverdien av organ-på-brikke-markedet er 103,44 millioner dollar i 2020.
Hva er den ledende anvendelsen av Organ-on-Chip Market?
Lunge-på-chip-segmentet dominerte markedet i 2020, og forventes å forbli dominerende i prognoseperioden, på grunn av lavere lungetransplantasjoner, noe som har ført til utvikling av laboratorieutviklede chips for å etterligne deres funksjoner og for medikamentscreening for luftveislidelser og forventes å drive segmentet.
♦ Last ned gratis prøve PDF nå (inkludert fullstendig innholdsfortegnelse, tabell og figurer):
https://www.alliedmarketresearch.com/request-sample/2555
Verdiforslag relatert til rapporten:
- Drevet med gratis analytikertimer og ekspertintervjuer med hver rapport
- Omfattende kvantitativ og kvalitativ innsikt på segment- og undersegmentnivå
- Covid 19 påvirker trender og perspektiv
- Granulær innsikt på globalt/regionalt/landnivå
- Dypt forankret innsikt om markedsdynamikk (drivere, begrensninger, muligheter) og forretningsmiljø
- Generell dekning på konkurranselandskap
- Vinnende imperativer
- Uttømmende dekning av ‘Strategic Developments’ registrert av ledende aktører i markedet
Covid-19 situasjon –
- Organ-on-Chip dukket opp som en gunstig teknologi for utvikling av vaksiner og legemidler, som var under kliniske studier. Dette påvirket i sin tur det globale organ-on-chip-markedet positivt.
- Denne trenden vil mest sannsynlig vedvare til pandemien er helt over.
♦ Bare snakk med ekspert for mer avklaring av [COVID-19 on Your Business}:
https://www.alliedmarketresearch.com/connect-to-analyst/2555
The lung on chip segment to maintain the dominant share –
Based on product, the lung segment holds more than one-fifth of the revenue in the global device-on-a-chip market in 2020 and is expected to lead way in the year 2030. Reduced lung turnover has led to the development. of on-a-chips designed in the laboratory to mimic their function. This makes the growth of the organ appear. The heart attack segment, on the other hand, will show the fastest CAGR of 32.8% from 2021 to 2030, due to the increase in heart problems among people across the world.
North America garnered the major share in 2020 –
Based on region, North America has the largest share in 2020, accounting for more than two-fifths of the global parts-on-chip market. This is due to the rapid adoption of advanced technology and the presence of major players across North America. The Asia-Pacific region, meanwhile, will see the fastest growth at a CAGR of 33.1% by 2030, due to increased R&D for the development of component-on-chip models.
Major Key Market Players in the Industry –
- BICO Group AB(Visikol)
- CN Bio Innovations Limited
- Elveflow
- Emulate, Inc.
- AxoSim Technologies LLC
- Nortis Inc.
- Tara Biosystems
- Organovo Holdings, Inc.
- Insphero AG
- Mimetas B.V.
♦ Inquire More About the Top Key Market Players Here:
https://www.alliedmarketresearch.com/purchase-enquiry/2555
Market: By Region Outlook
- North America (U.S., Canada, Mexico)
- Europe (UK, Germany, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
- LAMEA (Brazil, South Africa, Turkey, Saudi Arabia, Rest of LAMEA)
Important Questions Being Answered by This Market Report Are –
Q1. What are the upcoming trends of Organ-on-Chip Market in the world?
Q2. Which are the top companies to hold the market share in Organ-on-Chip?
Q3. Which is the largest regional market for Organ-on-Chip?
♦ Request for Customization:
https://www.alliedmarketresearch.com/request-for-customization/2555
Depending on type, the organ-on-chip market analysis lung-on-chip segment generated maximum revenue in 2020, accounting for $21.37 million. The heart-on-chip segment is expected to witness highest CAGR of 32.8% during the forecast period.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]lliedmarketresearch.com
Web: https://www.alliedmarketresearch.com